LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

LAVA Therapeutics NV
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LAVA Therapeutics NV
Retained Earnings Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Retained Earnings
-$136.1m
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Retained Earnings
-$267.3m
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
0%
ProQR Therapeutics NV
NASDAQ:PRQR
Retained Earnings
-€410.6m
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Retained Earnings
-$1.1B
CAGR 3-Years
-32%
CAGR 5-Years
-11%
CAGR 10-Years
-18%
argenx SE
XBRU:ARGX
Retained Earnings
-$1.6B
CAGR 3-Years
-37%
CAGR 5-Years
-58%
CAGR 10-Years
-51%
Merus NV
NASDAQ:MRUS
Retained Earnings
-$937.5m
CAGR 3-Years
-27%
CAGR 5-Years
-34%
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Retained Earnings?
Retained Earnings
-136.1m USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Retained Earnings amounts to -136.1m USD.

What is LAVA Therapeutics NV's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
-61%

Over the last year, the Retained Earnings growth was -37%. The average annual Retained Earnings growth rates for LAVA Therapeutics NV have been -61% over the past three years .

Back to Top